Vaccine Manufacturers Need Plans To Cut Adventitious Agents By October
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA is sending two rounds of letters to different sets of companies asking for the plans as part of the fall-out from the issues seen in rotavirus vaccines.